Canaccord Genuity Remains Bullish on ATARA Biotherapeutics (ATRA)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. AXP
7. TMUS
8. SPY
9. CVS
10. UNH

Go back to Canaccord Genuity Remains Bullish on ATARA Biotherapeutics (ATRA)

Cowen Starts Atara Biotherapeutics (ATRA) at Outperform

January 26, 2018 5:42 AM EST

Cowen initiates coverage on Atara Biotherapeutics (NASDAQ: ATRA) with an Outperform rating.

Analyst Eric Schmidt highlights that ATRA creates novel, off-the-shelf T cell therapies for treating cancer, viral infections, and autoimmune disorders. Lead candidate tab-cel is in pivotal study for EBV+ PTLD, a... More